HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abdelouahid Samadi Selected Research

ethyl 5- amino- 2- methyl- 6,7,8,9- tetrahydrobenzo(b)(1,8)naphthyridine- 3- carboxylate

9/2013PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abdelouahid Samadi Research Topics

Disease

22Alzheimer Disease (Alzheimer's Disease)
03/2024 - 05/2009
5Neuroblastoma
10/2013 - 07/2010
2Brain Ischemia (Cerebral Ischemia)
09/2013 - 01/2011
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2013 - 01/2011
2Stroke (Strokes)
09/2012 - 01/2012
2Vascular Diseases (Vascular Disease)
01/2011 - 08/2010
1Stomach Neoplasms (Stomach Cancer)
01/2024
1Neoplasms (Cancer)
01/2024
1Cognitive Dysfunction
01/2017
1Gliosis
01/2017
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2014
1Infarction (Infarctions)
09/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2013
1Memory Disorders (Memory Loss)
09/2013
1Nervous System Diseases (Neurological Disorders)
06/2013
1Inflammation (Inflammations)
05/2013
1Ischemia
09/2012

Drug/Important Bio-Agent (IBA)

6Cholinesterases (Cholinesterase)IBA
06/2014 - 12/2011
6Monoamine Oxidase (MAO)IBA
06/2014 - 09/2011
5oligomycin AIBA
04/2019 - 07/2010
5RotenoneIBA
04/2019 - 07/2010
5Tacrine (Cognex)FDA Link
04/2019 - 05/2009
4Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2024 - 09/2011
4LigandsIBA
04/2019 - 05/2009
4N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA
01/2017 - 10/2013
4Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
06/2014 - 12/2011
4Donepezil (Aricept)FDA LinkGeneric
06/2014 - 12/2011
4Oxidoreductases (Dehydrogenase)IBA
06/2014 - 06/2012
4AminesIBA
03/2014 - 12/2011
3AntioxidantsIBA
03/2014 - 01/2011
3Cholinergic Agents (Cholinergics)IBA
01/2011 - 05/2010
2quinolineIBA
01/2024 - 01/2012
2Scopolamine (Hyoscine)FDA Link
01/2017 - 09/2013
2EnzymesIBA
03/2014 - 06/2012
2Neuroprotective AgentsIBA
09/2013 - 01/2011
2nitronesIBA
01/2012 - 01/2011
1Okadaic AcidIBA
04/2019
1MetalsIBA
06/2014
1propargylamineIBA
06/2014
1Oxyquinoline (8 Hydroxyquinoline)FDA Link
06/2014
1Chelating AgentsIBA
06/2014
1AmidesIBA
03/2014
1Carboxylic AcidsIBA
03/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2014
1Galantamine (Galanthamine)FDA LinkGeneric
09/2013
1Muscarinic AntagonistsIBA
09/2013
1MelatoninIBA
09/2013
1ethyl 5- amino- 2- methyl- 6,7,8,9- tetrahydrobenzo(b)(1,8)naphthyridine- 3- carboxylateIBA
09/2013
1ButyrylcholinesteraseIBA
06/2013
1AcetylcholinesteraseIBA
06/2013
1HydrazinesIBA
06/2013
1human AOC3 proteinIBA
06/2013
1indoleIBA
06/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2013
1Oxygen (Dioxygen)IBA
09/2012
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1OxidesIBA
09/2012
1Calcium Channels (Calcium Channel)IBA
06/2011
1compound 17IBA
08/2010
1benzocycloheptapyridineIBA
08/2009
1Protein Kinases (Protein Kinase)IBA
08/2009
11,4-dihydropyridine (dihydropyridine)IBA
05/2009

Therapy/Procedure

5Therapeutics
01/2024 - 09/2011